Skip to main content
. Author manuscript; available in PMC: 2020 Jun 4.
Published in final edited form as: Mucosal Immunol. 2019 Dec 4;13(3):471–480. doi: 10.1038/s41385-019-0238-1

Figure 1. Study Schedule.

Figure 1

Animals (n=3 per group) were treated with enrofloxacin, cephalexin or paromomycin for nine days, or clindamycin for six days. Two sets of samples were collected prior to the treatment. During the treatments, non-invasive samples were collected three times and mucosal samples collected once. Animals were tracked for 63 days after initiation of the antibiotic treatments.